1 |
Owen PE, Glaister JR. Gaunt IF. and Pullinger DH. Inhalation toxicity studies with 1,3-butadiene. III. Two years toxicity/carcinogenicity study in rats, Am. Ind. Hyg. Assoc. J. 1987; 48: 407-413
DOI
ScienceOn
|
2 |
Lauwerys RR. and Hoet P. Industrial chemical exposure?Guidelines for biological monitoring, Lewis Publishers(2nd Eds), 1993; 1-13
|
3 |
Lee J.H. and Shin H.S.: Determination of hemoglobin adducts farmed in rats exposed orally with 3,3'-dichlorobenzidine by GC/MS-SIM. Toxicology and Industrial Health, 2002;18; 191-199
DOI
ScienceOn
|
4 |
Lee J.H. and Shin H.S. Measurement of hemoglobin adducts in female mice inhaled with 1,3-butadiene by using GC/MS. Kor. J. Env. Hlth. 2004; 30(4):301-307
과학기술학회마을
|
5 |
McMichael AJ, Spirtas R, Gamble JF. Mortality among rubber workers: relationship to specific jobs, J Occup Med 1976; 18;118-185
|
6 |
Meinhardt TJ, Lemen RA, Crandall MS. Environmental epidemiologic investigations of the styrcne-butdiene rubber industry: mortality patterns with discussion of the hematopoietic and lymphatic malignancies, Scand J Work Environ Health 1982;8;250-259
DOI
ScienceOn
|
7 |
Melnick RL. Huff J, Chou J. and Miller RA. Carcinogenicity of 1,3-butadiene in B6C3F1 mice at low exposure concentrations, Cancer Res. 1990;50:6592-6599
|
8 |
Mowrer JM. T?rnqvist S. Jensen and Ehrenberg L. Edman degradation applied to hemoglobin for monitoring occupational exposure to alkylating agents. Toxicol. Environ. Chem. 1986;11:215-231
DOI
ScienceOn
|
9 |
Osterman-Golkar M, Moss O, James A, Bryant MS, Tumer M, and Bond JA. Epoxybutene-hemoglobin adducts in rat and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene, Toxicology and Applied Pharmacology, 1998; 150:166-173
DOI
ScienceOn
|
10 |
Phillips DH and Arlt VM, The 32P-postlabeling assey for DNA adducts, Nature ProtocoIs-Electronic Edition, 2007; 2(11):2772-2781
|
11 |
Swenberg JA. Koc H, Upton PS, Georguieva N, Ranasmghe A, Walker YE. and Henderson R. Using DNA and hemoglobin adducts to improve the risk assessment of butadiene, Chemico-Biological Interactions, 2001 ; 135-136, 387-403
DOI
ScienceOn
|
12 |
주귀돈, 정동극, 이종성, 최성봉, 신재훈, 최영옥, 석유화학제조 공정에서 발생하는 유해화학물질 노출실태파악-벤젠 및 1,3-부타디엔 중심으로-, 한국산업안전보건공단/산업안전보건연구원, 2004; 1-50
|
13 |
산업안전보건연구원, 여천공단 근로자 건강관리 및 작업환경 실태조사, 한국산업안전보건공단/산업안전보건연구원, 1997;1-254
|
14 |
산업안전보건연구원, 여천공단근로자 건강관리 및 작업환경 실태조사, 한국산업안전보건공단/산업안전보건연구원, 2009; 1-300
|
15 |
ACGIH. Threshold limit values and biological exposure indices. American Conference of Governmental Industrial Hygienists. Cincinnati, OH, USA. 2002; 1-184
|
16 |
Boogaard PJ, Van Sittert NJ and Megens HJ. Urinart metabolites and Hemoglobin adducts as biomarkers of exposure to 1,3- butadiene: a basis for 1,3-butadiene cancer risk assessment, Chemico-Biological Interactions 2001; 135-136, 695-701
DOI
ScienceOn
|
17 |
Albrecht OE, Filser JE. and Neumann HG. Biological monitoring of 1,3-butadiene: species differences in hemoglobin binding in rats and mouse, in : Sorsa M, Peltonen K, Vainio H. Hemminki K(eds.) ; Butadiene and styrene: Assessment of health hazards, IARC Scientific Publications, Lyon. 1993; 135-142
|
18 |
Albertini RJ, Sram RJ, Vacek PM, Lynch J, Wright M, Nicklas JA, Boogaard PB. Henderson RF, Swenberg JA, Tates AD. and Ward Jr, JB. Biomarkers for assessing occupational exposure to 1,3-butadiene, Chemico-Biological Interactions, 2001;135-136, 429-453
DOI
ScienceOn
|
19 |
Bernard A. and Lauwery R. Present status and trends in biological monitoring of exposure to industrial chemicals, J. Occup. Med. 1986:28;559
|
20 |
Henderson RF, Bechtold WE. Sabourin PJ, Maples KR. and Dahl AR. Species differences in the metabolism of 1,3-butadiene in vivo. In 1,3-butadiene, IARC monographs on the evaluation of carcinogenic risks to humans, 1999;71:109
|
21 |
Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M and Miller RA. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure, Science(Washington, D.C.), 1985;548-549
|
22 |
IARC, 1,3-butadiene, IARC monographs on the evaluation of carcinogenic risks to humans, 1999;71:109-130
|
23 |
IARC, IARC monographs on the evaluation of carcinogenic risks to humans. 1992; 54;231-310
|
24 |
US Environmental Protection Agency. Mutagenicity and carcinogenicity assessment of 1,3-butadiene. Office of Health and Environmental Assessment, Office of Research and Development, Washington DC, EPA/600/8-85/004F, 1985; 1-200
|
25 |
노동부, 화학물질 및 물리적 인자의 노출기준, 노동부고시 제 2008-26호, 2008; 19
|
26 |
US Environmental Protection Agency. Health risk assessmenl of 1,3-butadiene. EPA/600/P-98/001F. National Office for Environmental Assessment-Washington Office. Office of Research and Development, US EPA, Washington, DC, USA, 2002;1-105
|